![Sam-Soo Lee](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sam-Soo Lee
Corporate Officer/Principal presso LG ELECTRONICS INC.
Profilo
Dr. Sam-Soo Lee is a Chief Strategy Officer at LG Electronics, Inc. and a Chief Executive Officer at Genuone Sciences, Inc.
Dr. Lee was previously employed as a Co-Chief Executive Officer & Director by Boryung Corp.
He received his doctorate degree from Seoul National University.
Posizioni attive di Sam-Soo Lee
Società | Posizione | Inizio |
---|---|---|
LG ELECTRONICS INC. | Corporate Officer/Principal | 05/06/2023 |
Genuone Sciences, Inc.
![]() Genuone Sciences, Inc. Pharmaceuticals: MajorHealth Technology Genuone Sciences, Inc. is a South Korean pharmaceutical company that specializes in the development and manufacturing of drugs. Genuone Sciences was founded in 2020 and is based in Seoul, South Korea. The company possesses expertise in pharmaceutical technology and have a fully equipped production facility for the production of drugs. The CEO of the company is Sam-Soo Lee. | Amministratore Delegato | - |
Precedenti posizioni note di Sam-Soo Lee
Società | Posizione | Fine |
---|---|---|
BORYUNG CORPORATION | Amministratore Delegato | - |
Formazione di Sam-Soo Lee
Seoul National University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
BORYUNG CORPORATION | Health Technology |
LG ELECTRONICS INC. | Consumer Durables |
Aziende private | 1 |
---|---|
Genuone Sciences, Inc.
![]() Genuone Sciences, Inc. Pharmaceuticals: MajorHealth Technology Genuone Sciences, Inc. is a South Korean pharmaceutical company that specializes in the development and manufacturing of drugs. Genuone Sciences was founded in 2020 and is based in Seoul, South Korea. The company possesses expertise in pharmaceutical technology and have a fully equipped production facility for the production of drugs. The CEO of the company is Sam-Soo Lee. | Health Technology |
- Borsa valori
- Insiders
- Sam-Soo Lee